Pfizer
Based in DC
🤖
AI Overview
With $1.6M in lobbying spend across 23 quarterly filings, Pfizer is a significant lobbying presence. They deploy 19 individual lobbyists
$1.6M
Total Lobbying Spend
23
Quarterly Filings
1
Lobbying Firms Used
19
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $320K |
| 2019 | $320K |
| 2020 | $80K |
| 2021 | $60K |
| 2022 | $180K |
| 2023 | $240K |
| 2024 | $120K |
| 2025 | $240K |
Lobbying Firms
WILLIAMS AND JENSEN, PLLC
What They Lobby For
- IP protections related to trade agreements; trade policies impacting pharmaceutical development.
- Medicare payment issues including the Independent Payment Advisory Board (IPAB) and Medicaid issues. Medicare Part D. CMMI Medicare Part B Demonstration.
- Labor- H.H.S Appropriations FY 2019; Policies impacting Medicare Part D, H.R. 1625, Consolidated Appropriations Act. H.R. 1892, the Bipartisan Budget Act of 2018.
- Tax issues affecting the pharmaceutical industry including international tax. Revenue proposals on international tax. Implementing of H.R. 1, Tax Cuts and Jobs Act.
- General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages; H.R. 1628, American Health Care Act of 2017. H.R. 1625, Consolidated Appropriations Act of 2018.
- Tax issues affecting the pharmaceutical industry including international tax. Implementing of H.R. 1, Tax Cuts and Jobs Act.
- General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages; H.R. 1625, Consolidated Appropriations Act of 2018.
- Medicare payment issues including the Independent Payment Advisory Board (IPAB) and Medicaid issues. Medicare Part D. CMMI Medicare Part B Demonstration; H.R. 6, Support for Patients and Communities Act.
- Labor- H.H.S Appropriations FY 2019; Policies impacting Medicare Part D; H.R. 6157, FY 2019 Appropriations.
- Tax issues affecting the pharmaceutical industry including international tax. Implementing of H.R. 1, Tax Cuts and Jobs Act, (P.L. 115-97).
Related Investigations
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.